Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 32.64B INR in the quarter ending June 30, 2025, with 0.62% growth. This brings the company's revenue in the last twelve months to 134.56B, up 4.62% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 134.35B with 6.25% growth.

• Revenue (ttm): 134.56B
• Revenue Growth: +4.62%
• P/S Ratio: 4.06
• Revenue / Employee: 8.98M
• Employees: 14,989
• Market Cap: 546.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	134.35B	7.90B	6.25%
Mar 31, 2024	126.45B	9.90B	8.49%
Mar 31, 2023	116.56B	-6.49B	-5.28%
Mar 31, 2022	123.05B	13.61B	12.44%
Mar 31, 2021	109.44B	2.87B	2.69%